Other Issues

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) released the following statement today after submitting comments to the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) regarding its Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients:

CHPA believes FDA should continuously evaluate food colors for safety using a transparent science-based approach. Policy changes should be science based and realistic about implementation timelines and the complex manufacturing realities involved.

(WASHINGTON, DC) – The Consumer Healthcare Products Association’s (CHPA) Health In Hand Foundation today announced its call for nominations for the 2025 U.S. Self-Care Marketing Awards. Winners will be announced at the 10th annual Health In Hand Foundation Gala on Nov. 12 at The Bellevue Hotel in Philadelphia.

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) today responded to an announcement from the Department of Commerce this week regarding the initiation of a Section 232 investigation into the national security implications of pharmaceutical imports, including finished drug products, active pharmaceutical ingredients (APIs), and other critical materials:

(JACKSON, Miss) – The Consumer Healthcare Products Association (CHPA) applauds Mississippi Representative Stacey Wilkes, Senator Hob Bryan, and Governor Tate Reeves for passing and signing legislation into law requiring all manufacturers of over-the-counter (OTC) medicines containing pseudoephedrine (PSE) to participate in supporting the costs and administration of the National Precursor Log Exchange (NPLEx) system – a real-time stop-sale technology that allows retailers to enforce PSE sales limits and assist law enforcement in preventing illegal PSE sales. This important step not only strengthens the NPLEx system overall, but it enhances its long-term viability in preventing illegal sales of medicines containing PSE in Mississippi.

CHPA applauds the introduction of H.R. 1219, the Oral Health Products Inclusion Act, which would increase access to certain oral care items, including toothbrushes, toothpaste, mouthwash, and other everyday oral care essentials by recognizing them as “qualified medical expenses” that can be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds.